Glucosamine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
* 1100mg Glucosamine (base) …which is equivalent to: | * 1100mg Glucosamine (base) …which is equivalent to: | ||
* 1400mg Glucosamine Sulphate, | * 1400mg Glucosamine Sulphate, | ||
* 1350mg N-Acetylglucosamine (NAG), | |||
* 1325mg Glucosamine HCl, or | * 1325mg Glucosamine HCl, or | ||
* 1858mg Glucosamine Sulphate 2KCl | * 1858mg Glucosamine Sulphate 2KCl | ||
[[Category:Ingredients]] | [[Category:Ingredients]] | ||
Latest revision as of 10:21, 17 March 2026
In 2018 the MHRA reviewed Glucosamine use and set a limit for food supplements.
Anything at or above 1178mg of Glucosamine (base) is deemed a pharmacological dose, food supplements would therefore have to be lower.
To ensure this clear space can be demonstrated, discussions between HFMA, CRN UK, and PAGB have led to an upper level, for guidance purposes only as follows:
- 1100mg Glucosamine (base) …which is equivalent to:
- 1400mg Glucosamine Sulphate,
- 1350mg N-Acetylglucosamine (NAG),
- 1325mg Glucosamine HCl, or
- 1858mg Glucosamine Sulphate 2KCl